Steve Miller - Net Worth and Insider Trading

Steve Miller Net Worth

The estimated net worth of Steve Miller is at least $10 Million dollars as of 2024-06-19. Steve Miller is the Chief Op. & Scientific Officer of Catalyst Pharmaceuticals Inc and owns about 647,457 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $10 Million. Details can be seen in Steve Miller's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steve Miller has not made any transactions after 2023-12-05 and currently still holds the listed stock(s).

Transaction Summary of Steve Miller

To

Steve Miller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steve Miller owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .

Click here to see the complete history of Steve Miller’s form 4 insider trades.

Insider Ownership Summary of Steve Miller

Ticker Comapny Transaction Date Type of Owner
CPRX Catalyst Pharmaceuticals Inc 2023-12-05 VP Development & Management

Steve Miller Latest Holdings Summary

Steve Miller currently owns a total of 1 stock. Steve Miller owns 647,457 shares of Catalyst Pharmaceuticals Inc (CPRX) as of December 5, 2023, with a value of $10 Million.

Latest Holdings of Steve Miller

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPRX Catalyst Pharmaceuticals Inc 2023-12-05 647,457 14.97 9,692,431

Holding Weightings of Steve Miller


Steve Miller Form 4 Trading Tracker

According to the SEC Form 4 filings, Steve Miller has made a total of 6 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 40,000 shares on December 5, 2023, which brought Steve Miller around $569,600.

Insider Trading History of Steve Miller

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steve Miller Trading Performance

GuruFocus tracks the stock performance after each of Steve Miller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steve Miller is 74.87%. GuruFocus also compares Steve Miller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steve Miller within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steve Miller's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steve Miller

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 57.68 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 57.91 LIMIT LIMIT LIMIT LIMIT LIMIT

Steve Miller Ownership Network

Ownership Network List of Steve Miller

No Data

Ownership Network Relation of Steve Miller

Insider Network Chart

Steve Miller Owned Company Details

What does Catalyst Pharmaceuticals Inc do?

Who are the key executives at Catalyst Pharmaceuticals Inc?

Steve Miller is the VP Development & Management of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Commercial Officer Carmen Jeffrey Del , Chief Medical Officer Gary Ingenito , and Chief Compliance/Legal Officer Brian Elsbernd .

Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary

Over the past 18 months, Steve Miller made 1 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 40,000. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 250,000 shares made by Alicia Grande , a net sale of 105,000 shares made by David S Tierney , and a net sale of 130,000 shares made by Gary Ingenito .

In summary, during the past 3 months, insiders sold 160,197 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 160,197 shares. During the past 18 months, 710,348 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 710,348 shares.

Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Pharmaceuticals Inc Insider Transactions

No Available Data

Steve Miller Mailing Address

Above is the net worth, insider trading, and ownership report for Steve Miller. You might contact Steve Miller via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.

Discussions on Steve Miller

No discussions yet.